Bollard Group Portfolio holdings
The Bollard Group, established in 1995, is a multi-family office that advises on investing, accounting, taxes and estate planning for high net worth individuals, trusts, charitable foundations and family companies. It is owned by its senior managers and controlled by Anastasios Parafestas. Parafestas also wholly owns Spinnaker Capital, an affiliate of Bollard that offers private funds in private equity, venture capital, hedge funds and real estate to eligible clients.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$167M |
| 2 |
Amazon
AMZN
|
+$5.51M |
| 3 |
Abbott
ABT
|
+$4.26M |
| 4 |
AGN
Allergan plc
AGN
|
+$2.31M |
| 5 |
Block Inc
XYZ
|
+$2.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$1.73M |
| 2 |
ADT Corp
ADT
|
+$915K |
| 3 |
ProShares UltraShort S&P500
SDS
|
+$791K |
| 4 |
Kinder Morgan
KMI
|
+$550K |
| 5 |
Altria Group
MO
|
+$425K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.67% |
| 2 | Energy | 13.72% |
| 3 | Utilities | 5.53% |
| 4 | Consumer Staples | 4.25% |
| 5 | Communication Services | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Boston Scientific
BSX
$64.3B
| $790M | 53.96% |
33,797,061
+7,727,095
| +30% | +$167M |
2013 Q2
12 quarters
|
|
2
Enterprise Products Partners
EPD
$82.6B
| $31.4M | 2.14% |
1,071,839
+15,576
| +1% | +$418K |
2013 Q2
12 quarters
|
|
|
MMP
3
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $28.1M | 1.92% |
369,393
+3,824
| +1% | +$271K |
2013 Q2
12 quarters
|
|
4
Eli Lilly
LLY
$1.29T
| $23.8M | 1.62% |
301,986
+1,066
| +0.4% | +$80.3K |
2013 Q2
12 quarters
|
|
5
Verizon
VZ
$192B
| $21.4M | 1.46% |
383,096
+3,628
| +1% | +$188K |
2013 Q2
12 quarters
|
|
6
AT&T
T
$149B
| $19.5M | 1.33% |
597,376
+6,324
| +1% | +$188K |
2013 Q2
12 quarters
|
|
7
NextEra Energy
NEE
$179B
| $18.8M | 1.28% |
576,512
+3,796
| +0.7% | +$114K |
2013 Q2
12 quarters
|
|
8
American Electric Power
AEP
$70.3B
| $18M | 1.23% |
257,395
+2,062
| +0.8% | +$135K |
2013 Q2
12 quarters
|
|
|
EEQ
9
DELISTED
Enbridge Energy Management Llc
EEQ
| $17.8M | 1.21% |
977,047
-7
| -0% | -$115 |
2013 Q2
12 quarters
|
|
|
BPL
10
DELISTED
Buckeye Partners, L.P.
BPL
| $15.6M | 1.06% |
221,585
+3,467
| +2% | +$243K |
2013 Q2
12 quarters
|
|
11
Boeing
BA
$136B
| $14.7M | 1.01% |
113,484
+905
| +0.8% | +$118K |
2013 Q2
12 quarters
|
|
12
Bristol-Myers Squibb
BMY
$130B
| $12.6M | 0.86% |
170,663
+715
| +0.4% | +$50.5K |
2013 Q2
12 quarters
|
|
13
PayPal
PYPL
$49.2B
| $12.1M | 0.83% |
330,800
| – | – |
2015 Q3
3 quarters
|
|
|
RAI
14
DELISTED
Reynolds American Inc
RAI
| $11.7M | 0.8% |
217,224
+1,542
| +0.7% | +$77.5K |
2014 Q3
7 quarters
|
|
15
PPL Corp
PPL
$26.9B
| $10.9M | 0.74% |
288,244
+2,671
| +0.9% | +$102K |
2013 Q2
12 quarters
|
|
16
Duke Energy
DUK
$101B
| $10.6M | 0.72% |
123,058
+1,150
| +0.9% | +$91.9K |
2013 Q2
12 quarters
|
|
|
TCP
17
DELISTED
TC Pipelines LP
TCP
| $10M | 0.69% |
175,405
+2,377
| +1% | +$129K |
2013 Q2
12 quarters
|
|
|
18
ProShares Short S&P500
SH
$955M
| $9.46M | 0.65% |
59,617
-10,693
| -15% | -$1.73M |
2013 Q2
12 quarters
|
|
19
Chevron
CVX
$429B
| $9.43M | 0.64% |
89,914
+765
| +0.9% | +$76.9K |
2013 Q2
12 quarters
|
|
|
20
Altria Group
MO
$131B
| $9.35M | 0.64% |
135,627
-6,634
| -5% | -$425K |
2013 Q2
12 quarters
|
|
|
21
Amazon
AMZN
$2.88T
| $9.21M | 0.63% |
257,520
+162,860
| +172% | +$5.51M |
2013 Q2
12 quarters
|
|
22
GE Aerospace
GE
$344B
| $8.96M | 0.61% |
59,421
+406
| +0.7% | +$59.2K |
2013 Q2
12 quarters
|
|
23
Weyerhaeuser
WY
$15B
| $8.38M | 0.57% |
281,477
+1,589
| +0.6% | +$48.9K |
2013 Q2
12 quarters
|
|
24
Southern Copper
SCCO
$140B
| $7.94M | 0.54% |
324,504
-7,849
| -2% | -$194K |
2013 Q2
12 quarters
|
|
25
Philip Morris
PM
$310B
| $7.91M | 0.54% |
77,719
+705
| +0.9% | +$70.3K |
2013 Q2
12 quarters
|
|
Similar funds
Bollard Group's Q2 2016 Portfolio in Review
As of Q2 2016, Bollard Group held 266 positions worth $1.46B, up 18% from $1.24B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Bollard Group deployed $49.8M of net new capital in Q2 2016, opening 5 new positions and adding to 172 existing holdings. Its largest new stake was Allergan plc: 10,000 shares worth $2.31M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 44% a quarter earlier, followed by Energy and Utilities.
On the sell side, the largest reduction was ProShares Short S&P500, an estimated $1.73M trimmed.
- Bollard Group's largest Q2 2016 buy was Allergan plc: 10,000 shares worth $2.31M.
- Bollard Group added most to Boston Scientific in Q2 2016, an estimated $167M increase.
- Bollard Group's biggest Q2 2016 reduction was ProShares Short S&P500, cutting an estimated $1.73M.
- Bollard Group fully exited ADT Corp in Q2 2016, selling an estimated $915K.
- Bollard Group's ten largest holdings make up 67% of its $1.46B portfolio in Q2 2016.
- Bollard Group opened 5 new positions and closed 8 in Q2 2016.
- Bollard Group's portfolio value rose 18% quarter-over-quarter to $1.46B.
Based on Bollard Group's 13F filing for Q2 2016, filed 20 Jul 2016.